Aug 11, 2026 09:40AM
Aug 5, 2026 04:06PM
Jul 29, 2026 07:00AM
Jul 17, 2026 09:55AM
Jul 7, 2026 06:16AM
Jun 17, 2026 07:01AM
May 22, 2026 09:20AM AbCellera Biologics (ABCL) PT Raised to $12 at Truist Securities
May 21, 2026 09:57AM
May 12, 2026 09:27AM
May 12, 2026 07:27AM
May 11, 2026 04:06PM
May 5, 2026 06:08AM
Apr 15, 2026 10:01AM
Apr 15, 2026 10:01AM Truist Securities Reiterates Buy Rating on AbCellera Biologics (ABCL)
Apr 9, 2026 04:08PM
Feb 24, 2026 04:15PM
Feb 14, 2026 10:00AM
Dec 18, 2025 09:01AM
Nov 7, 2025 06:08AM
Nov 6, 2025 04:10PM
Aug 13, 2025 10:05AM Benchmark Reiterates Hold Rating on AbCellera Biologics (ABCL)
Aug 7, 2025 04:23PM
Jul 7, 2025 06:20AM
May 30, 2025 01:00PM
May 16, 2025 10:06AM
May 14, 2025 05:00PM
May 12, 2025 03:30PM
May 8, 2025 04:05PM AbCellera (ABCL) Misses Q1 EPS by 1c
Apr 29, 2025 03:01PM
Mar 3, 2025 09:41AM
Feb 27, 2025 04:19PM
Jan 13, 2025 09:09AM
Nov 5, 2024 08:14AM
Nov 4, 2024 04:08PM
Aug 23, 2024 11:57AM KeyBanc Reiterates Overweight Rating on AbCellera Biologics (ABCL)
Aug 20, 2024 09:15AM
Aug 6, 2024 04:08PM
Jul 31, 2024 09:01AM
Jun 28, 2024 10:34AM

444,171 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All